BACH FLOWER REMEDIES LIMITED

Active United Kingdom

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical products
B

BACH FLOWER REMEDIES LIMITED

Manufacture of basic pharmaceutical products

Founded 8 Apr 1993 Active United Kingdom 0 employees website.com
Manufacture of basic pharmaceutical products

Previous Company Names

BEALAW (339) LIMITED 8 Apr 1993 — 15 Dec 1993
Accounts Submitted 26 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 31 Mar 2026 Next due 14 Apr 2027 10 months remaining
Net assets £12M £1M 2024 year on year
Total assets £12M £2M 2024 year on year
Total Liabilities £462K £494K 2024 year on year
Charges 11
7 outstanding 4 satisfied

Contact & Details

Contact

Full company profile for BACH FLOWER REMEDIES LIMITED (02807916), an active company based in United Kingdom. Incorporated 8 Apr 1993. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£11.85M

Decreased by £1.46M (-11%)

Total Liabilities

£462.00k

Decreased by £494.00k (-52%)

Turnover

£11.88M

Increased by £902.00k (+8%)

Employees

N/A

Debt Ratio

4%

Decreased by 3 (-43%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

A Nelson & Co Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

A Nelson & Co Limited

United Kingdom

Active
Notified 8 Apr 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

BACH FLOWER REMEDIES LIMITED Current Company

Charges

Charges

7 outstanding 4 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Apr 2026OfficersAppointment of Ms Lindsay Claire Reisser-Weston as director on 29 Apr 2026
31 Mar 2026Confirmation StatementConfirmation statement made on 31 Mar 2026 with no updates
10 Dec 2025OfficersTermination of Michael Lockett as director on 10 Dec 2025
1 Dec 2025OfficersAppointment of Mr Bogdan Ionescu as director on 17 Nov 2025
30 Nov 2025OfficersTermination of Simon Jonathon Hodge as director on 30 Nov 2025
30 Apr 2026 Officers

Appointment of Ms Lindsay Claire Reisser-Weston as director on 29 Apr 2026

31 Mar 2026 Confirmation Statement

Confirmation statement made on 31 Mar 2026 with no updates

10 Dec 2025 Officers

Termination of Michael Lockett as director on 10 Dec 2025

1 Dec 2025 Officers

Appointment of Mr Bogdan Ionescu as director on 17 Nov 2025

30 Nov 2025 Officers

Termination of Simon Jonathon Hodge as director on 30 Nov 2025

Recent Activity

Latest Activity

Appointment of Ms Lindsay Claire Reisser-Weston as director on 29 Apr 2026

1 months ago on 30 Apr 2026

Confirmation statement made on 31 Mar 2026 with no updates

2 months ago on 31 Mar 2026

Termination of Michael Lockett as director on 10 Dec 2025

5 months ago on 10 Dec 2025

Appointment of Mr Bogdan Ionescu as director on 17 Nov 2025

6 months ago on 1 Dec 2025

Termination of Simon Jonathon Hodge as director on 30 Nov 2025

6 months ago on 30 Nov 2025